Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
/* OVERVIEW */ ?>
Alyve Rating Review
Pitch rating powered by CROWDRATING™
Rated on 29/04/2021
Log in to view target
£1,500,367
pre-money valuation
9.09%
equity available
222
investors
£1,026
pledge per investor
12340284
company number
Active
company status
29/11/2019
incorporated 4 years
£7.50
share price
Previous Funding rounds
08 Apr 24 | Crowdcube | £227,782 / 152% | 79.67% |
News
Alyve: Delivering targeted nutrition with all-in-one personalised supplements - NutraIngredients.com
20/03/2024 NutraIngredients.com
Interview: Alyve Health's CEO Shashank Avadhani On Tailoring Health Plans to Meet Corporate & Startups' Needs - TechGraph
26/06/2023 TechGraph
Alyve Health aims to democratize healthcare coverage with integrated platform - Entrackr
15/05/2023 Entrackr
NCS America, Inc. Announces Name Change to Alyve Medical, Inc. - Business Wire
12/04/2022 Business Wire
Exclusive HealthBrief | Shashank Avadhani, Alyve Health: Unifying the fragmented healthcare system - Mediabrief
16/03/2023 Mediabrief
GigVistas partners with Alyve Health to launch health plans for gig workers - The Economic Times
23/12/2021 The Economic Times
Alyve Medical Announces New Headquarters and Launch of Rental Program for Neuralign S @Home - Business Wire
07/02/2023 Business Wire
India needs simplified healthcare access for all people: Alyve Health - Bizz Buzz
03/03/2023 Bizz Buzz
Valuations in Health and Fitness
Carocell Bio Limited | £6.1M |
PulmoBioMed | £4.0M |
Optimise BP | £474.1K |
What the ratings mean
RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.